Go to content
UR Home

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

Neuenhahn, M ; Albrecht, J ; Odendahl, M ; Schlott, F ; Dössinger, G ; Schiemann, M ; Lakshmipathi, S ; Martin, K ; Bunjes, D ; Harsdorf, S ; Weissinger, E M ; Menzel, H ; Verbeek, M ; Uharek, L ; Kröger, N ; Wagner, E ; Kobbe, G ; Schroeder, T ; Schmitt, M ; Held, G ; Herr, W ; Germeroth, L ; Bonig, H ; Tonn, T ; Einsele, H ; Busch, D H ; Grigoleit, G U


Cytomegalovirus (CMV) infection is a common, potentially life-threatening complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT). We assessed prospectively the safety and efficacy of stem cell-donor-or third-party-donor-derived CMV-specific T cells for the treatment of persistent CMV infections after allo-HSCT in a phase I/IIa trial. Allo-HSCT patients with ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons